Literature DB >> 23832539

Transcription factor AP1 binds the functional region of the promoter and regulates gene expression of human PPARdelta in LoVo cell.

Xiaogang Jiang1, Xudong Yang, Yan Han, Shemin Lu.   

Abstract

Peroxisome proliferator-activated receptor δ gene (PPARδ) is correlated with carcinogenesis of colorectal cancer, but the regulation of its gene transcription remains unclear. We herein report that AP1 binds the promoter and regulates PPARδ gene expression. With a luciferase reporter system, we identified a functional promoter region of 30 bp of PPARδ gene by deletion and electrophoretic mobility shift assays (EMSA). Using site-directed mutagenesis and decoy analyses, we demonstrated that AP1 bound the functional transcriptional factor binding site in a region extending from -176 to -73 of the PPARδ promoter, which was confirmed using EMSA and supershift assays. Consequently, inhibition of the AP1 binding site led to decreased PPARδ mRNA. Our study demonstrated that AP1 is the transcriptional factor that contributes to PPARδ expression in LoVo cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23832539     DOI: 10.1007/s13277-013-0943-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  28 in total

Review 1.  Peroxisome proliferator-activated receptors: nuclear control of metabolism.

Authors:  B Desvergne; W Wahli
Journal:  Endocr Rev       Date:  1999-10       Impact factor: 19.871

Review 2.  The PPARs: from orphan receptors to drug discovery.

Authors:  T M Willson; P J Brown; D D Sternbach; B R Henke
Journal:  J Med Chem       Date:  2000-02-24       Impact factor: 7.446

3.  PPARδ agonists suppress angiogenesis in a VEGFR2-dependent manner.

Authors:  Markus Meissner; Igor Hrgovic; Monika Doll; Roland Kaufmann
Journal:  Arch Dermatol Res       Date:  2010-11-03       Impact factor: 3.017

Review 4.  The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.

Authors:  S A Kliewer; J M Lehmann; M V Milburn; T M Willson
Journal:  Recent Prog Horm Res       Date:  1999

Review 5.  AP-1 in mouse development and tumorigenesis.

Authors:  W Jochum; E Passegué; E F Wagner
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

6.  Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes.

Authors:  W Chen; G T Bowden
Journal:  Oncogene       Date:  1999-12-09       Impact factor: 9.867

7.  PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine.

Authors:  Karen R Reed; Owen J Sansom; Anthony J Hayes; Andreas J Gescher; Douglas J Winton; Jeffrey M Peters; Alan R Clarke
Journal:  Oncogene       Date:  2004-11-25       Impact factor: 9.867

8.  Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis.

Authors:  Xiangsheng Zuo; Zhanglong Peng; Micheline J Moussalli; Jeffrey S Morris; Russell R Broaddus; Susan M Fischer; Imad Shureiqi
Journal:  J Natl Cancer Inst       Date:  2009-05-12       Impact factor: 13.506

9.  Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology.

Authors:  O Takayama; H Yamamoto; B Damdinsuren; Y Sugita; C Y Ngan; X Xu; T Tsujino; I Takemasa; M Ikeda; M Sekimoto; N Matsuura; M Monden
Journal:  Br J Cancer       Date:  2006-09-12       Impact factor: 7.640

10.  PPAR-delta in Vascular Pathophysiology.

Authors:  Nanping Wang
Journal:  PPAR Res       Date:  2009-01-06       Impact factor: 4.964

View more
  2 in total

1.  PPARβ in yellow catfish Pelteobagrus fulvidraco: molecular characterization, tissue expression and transcriptional regulation by dietary Cu and Zn.

Authors:  Wen-Jing You; Xiao-Ying Tan; Guang-Hui Chen; Chuan-Chuan Wei; Dan-Dan Li
Journal:  Fish Physiol Biochem       Date:  2018-02-01       Impact factor: 2.794

2.  MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet.

Authors:  Jun He; Megan T Quintana; Jenyth Sullivan; Traci L Parry; Trisha J Grevengoed; Jonathan C Schisler; Joseph A Hill; Cecelia C Yates; Rudo F Mapanga; M Faadiel Essop; William E Stansfield; James R Bain; Christopher B Newgard; Michael J Muehlbauer; Yipin Han; Brian A Clarke; Monte S Willis
Journal:  Cardiovasc Diabetol       Date:  2015-08-05       Impact factor: 9.951

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.